Summary
GHRP-2 and Selank are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: GHRP-2 is more often discussed in the realm of Metabolic and endocrine and Musculoskeletal health, whereas Selank is more often associated with the realm of Neurology and brain health and Immunology and inflammation. They also influence different molecular systems, with GHRP-2 tracking more closely to Ghrelin receptor while Selank centers more on GPCR receptor. GHRP-2 has a more synthetic design origin, while Selank is closer to synthetic analog background with GHRP-2 in Clinical phase 1 and Selank approved for Research use only. GHRP-2 incorporates d-amino acid substitution and amidation features that are not part of Selank, while their sequence patterns also diverge, with GHRP-2 showing protein-mimetic sequence features and Selank showing proline-rich features.